Drug company experts advised staff to withhold data about SSRI use in children.
Wayne
W
Kondro
Barbara
B
Sibbald
D000293:Adolescent; D018687:Antidepressive Agents, Second-Generation / Q000037:antagonists & inhibitors* / Q000592:standards / Q000627:therapeutic use*; D002648:Child; D002669:Child Welfare; D002986:Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D003863:Depression / Q000188:drug therapy; D004345:Drug Industry / Q000592:standards; D006801:Humans; D009656:North America; D017374:Paroxetine / Q000037:antagonists & inhibitors* / Q000592:standards / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000592:standards / Q000627:therapeutic use*; D000078329:Workforce
D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors